Clinical Research Directory
Browse clinical research sites, groups, and studies.
Chinese Medicine in Treating Insomnia
Sponsor: Chinese University of Hong Kong
Summary
This is a randomized, double-blinded, placebo-controlled clinical trial. Eligible participants will randomized into either treatment group (CM granules) or placebo group (placebo granules) for 6 weeks, followed by a post-treatment visit at week 9. The primary outcome is the change in Pittsburgh Sleep Quality Index (PSQI) at week 6.
Official title: Efficacy and Safety of Modified Suan ZaoRen Tang-TianWang BuXin Dan in the Treatment of Chronic Insomnia: A Randomized, Double-blinded, Placebo-controlled Trial
Key Details
Gender
All
Age Range
18 Years - 65 Years
Study Type
INTERVENTIONAL
Enrollment
76
Start Date
2025-09-25
Completion Date
2027-08
Last Updated
2026-07-27
Healthy Volunteers
No
Conditions
Interventions
Modified Suan ZaoRen Tang-TianWang BuXin Dan
Chinese medicine granules for 6 weeks
Placebo
Placebo granules for 6 weeks
Locations (1)
Hong Kong Institute of Integrative Medicine
Shatin, Hong Kong